Product Information
ETHOSUXIMIDE 250 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $0.2523 per EA under NDC 69452015220. Its NADAC has been published 484 times since Mar 22, 2017.
Strength
250 mg/1
Manufacturer
Bionpharma Inc.NDC
69452015220
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040430On Market Since
10/21/2016
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG CAPSULE has been published 484 times since Mar 22, 2017, and over the history we have for it it has declined 77.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2523 per EA |
|---|---|
| All-time high | $1.1198 (Apr 12, 2017) |
| All-time low | $0.1798 (Nov 20, 2024) |
| 52-week high | $0.2649 |
| 52-week low | $0.2210 |
| Median price | $0.5674 |
| Average price | $0.5634 |
| Largest weekly change | +76.6% (Jan 19, 2022) |
| Weeks tracked | 484 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG CAPSULE, manufactured by Bionpharma Inc., is $0.2523 per EA (NDC 69452015220), effective Jun 24, 2026.
How has the price of ETHOSUXIMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has declined 77.5%. It has been tracked across 484 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG CAPSULE?
Since Mar 22, 2017, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has ranged from a low of $0.1798 (Nov 20, 2024) to a high of $1.1198 (Apr 12, 2017), with a median of $0.5674 per EA.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ETHOSUXIMIDE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures ETHOSUXIMIDE 250 MG CAPSULE?
ETHOSUXIMIDE 250 MG CAPSULE (NDC 69452015220) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification